Skip to main content

Table 1 Demographic and laboratorial data at baseline

From: Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis

Characteristic

Control (n = 9)

PDR (n = 8)

IVR (n = 9)

P value

Age (years)

53.9 ± 12.5

47.5 ± 10.7

49.1 ± 8.6

> 0.05

Gender (male/female)

4/5

4/4

4/5

> 0.05

FBG(mmol/l)

6.0 ± 0.7

9.7 ± 0.9*

9.6 ± 3.3*

< 0.01

HbA1C(%)

9.1 ± 1.3

8.8 ± 1.3

> 0.05

Lens status (phakic/pseudophakic)

4/5

3/5

4/5

> 0.05

Indication for surgery

    

 VH

8 (100%)

9 (100%)

> 0.05

 TRD

3 (37.5%)

3 (33.3%)

> 0.05

  1. VH vitreous hemorrhage, TRD tractional retinal detachment
  2. *Statistically significant difference with control group
  3. There were no significant differences in demographic and experimental data among groups except for a statistically significant difference in fasting plasma glucose between the control group and the other two groups (P < 0.01)